Both in Pharmaceuticals
Propanc Biopharma vs Revelation Biosciences
Over the past year PPCB returned −98.9% and REVB returned −85.8%; their daily moves had a correlation of -0.07.
PPCB −98.9% REVB −85.8%Growth of $1, one year, split-adjusted
| Metric | PPCB | REVB |
|---|---|---|
| Price | $0.5123 | $0.8140 |
| Market cap | $3.2M | $3.2M |
| Today | −3.96% | −5.27% |
| 1 month | −62.1% | −22.5% |
| 6 months | −79.9% | −31.6% |
| Year to date | −96.2% | −74.6% |
| 1 year | −98.9% | −85.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $832.0K | $11.5M |
| Dividend yield | — | — |
| Volatility (60d) | 212.5% | 63.0% |
| Short % of float | 1.2% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).